Primary Site >> Colorectal Cancer

Gene >> MAP2K2

Journal: J Biol Chem. 2002 Oct 11;277(41):38205-11.
Title: Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells.
Author: Fukuda, Ryo|Hirota, Kiichi|Fan, Fan|Jung, Young Do|Ellis, Lee M|Semenza, Gregg L
PMID: 12149254
Journal: Anticancer Res. 2006 Mar-Apr;26(2A):1029-37.
Title: EGF receptor-related protein (ERRP) inhibits invasion of colon cancer cells and tubule formation by endothelial cells in vitro.
Author: Rishi, Arun K|Parikh, Rakesh|Wali, Anil|Durko, Lukasz|Zhang, Liyue|Yu, Yingjie|Majumdar, Adhip P N
PMID: 16619503
Journal: Hum Mutat. 2008 Mar;29(3):441-50.
Title: Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD).
Author: Bentivegna, Steven|Zheng, Jianbiao|Namsaraev, Eugeni|Carlton, Victoria E H|Pavlicek, Adam|Moorhead, Martin|Siddiqui, Farooq|Wang, Zhiyong|Lee, Liana|Ireland, James S|Suyenaga, Kent|Willis, Thomas D|Faham, Malek|Seymour, Albert B
PMID: 18186519
Journal: Biochem Biophys Res Commun. 2008 Aug 8;372(4):845-9.
Title: Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells.
Author: Shama, Jessica|Garcia-Medina, Raquel|Pouyssegur, Jacques|Vial, Emmanuel
PMID: 18533112
Journal: J Biol Chem. 2008 Dec 12;283(50):35295-304.
Title: Unbiased screening for transcriptional targets of ZKSCAN3 identifies integrin beta 4 and vascular endothelial growth factor as downstream targets.
Author: Yang, Lin|Zhang, Li|Wu, Qiuyu|Boyd, Douglas D
PMID: 18940803
Journal: BMC Cancer. 2008 Nov 17;8:337.
Title: Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.
Author: Voisin, Laure|Julien, Catherine|Duhamel, Stephanie|Gopalbhai, Kailesh|Claveau, Isabelle|Saba-El-Leil, Marc K|Rodrigue-Gervais, Ian Gael|Gaboury, Louis|Lamarre, Daniel|Basik, Mark|Meloche, Sylvain
PMID: 19014680
Journal: PLoS One. 2009 May 27;4(5):e5717.
Title: Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors.
Author: Jaiswal, Bijay S|Janakiraman, Vasantharajan|Kljavin, Noelyn M|Eastham-Anderson, Jeffrey|Cupp, James E|Liang, Yuxin|Davis, David P|Hoeflich, Klaus P|Seshagiri, Somasekar
PMID: 19492075
Journal: Sci Signal. 2011 Mar 29;4(166):ra17.
Title: Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells.
Author: Little, Annette S|Balmanno, Kathryn|Sale, Matthew J|Newman, Scott|Dry, Jonathan R|Hampson, Mark|Edwards, Paul A W|Smith, Paul D|Cook, Simon J
PMID: 21447798
Journal: Sci Signal. 2011;4(170):er2.
Title: A correction to the research article titled: "Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells" by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P
Author: Little, Annette S|Balmanno, Kathryn|Sale, Matthew J|Newman, Scott|Dry, Jonathan R|Hampson, Mark|Edwards, Paul A W|Smith, Paul D|Cook, Simon J
PMID: 21674991
Journal: Inflamm Bowel Dis. 2012 Jan;18(1):94-100.
Title: miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes.
Author: Pekow, Joel R|Dougherty, Urszula|Mustafi, Reba|Zhu, Hongyan|Kocherginsky, Masha|Rubin, David T|Hanauer, Stephen B|Hart, John|Chang, Eugene B|Fichera, Alessandro|Joseph, Loren J|Bissonnette, Marc
PMID: 21557394
Journal: Mol Cancer Ther. 2012 Mar;11(3):720-9.
Title: Comprehensive predictive biomarker analysis for MEK inhibitor GSK1120212.
Author: Jing, Junping|Greshock, Joel|Holbrook, Joanna Dawn|Gilmartin, Aidan|Zhang, Xiping|McNeil, Elizabeth|Conway, Theresa|Moy, Christopher|Laquerre, Sylvie|Bachman, Kurt|Wooster, Richard|Degenhardt, Yan
PMID: 22169769
Journal: Br J Cancer. 2013 Sep 17;109(6):1562-9.
Title: Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.
Author: Beloueche-Babari, M|Jamin, Y|Arunan, V|Walker-Samuel, S|Revill, M|Smith, P D|Halliday, J|Waterton, J C|Barjat, H|Workman, P|Leach, M O|Robinson, S P
PMID: 23942066
Journal: Clin Cancer Res. 2013 Nov 15;19(22):6219-29.
Title: Overcoming IGF1R/IR resistance through inhibition of MEK signaling in colorectal cancer models.
Author: Flanigan, Sara A|Pitts, Todd M|Newton, Timothy P|Kulikowski, Gillian N|Tan, Aik Choon|McManus, Martine C|Spreafico, Anna|Kachaeva, Maria I|Selby, Heather M|Tentler, John J|Eckhardt, S Gail|Leong, Stephen
PMID: 24045180
Journal: Recent Results Cancer Res. 2014;201:241-8.
Title: Trametinib.
Author: Zeiser, Robert
PMID: 24756797
Journal: Mol Nutr Food Res. 2016 Sep;60(9):1912-23.
Title: Comparison of anti-inflammatory mechanisms of mango (Mangifera Indica L.) and pomegranate (Punica Granatum L.) in a preclinical model of colitis.
Author: Kim, Hyemee|Banerjee, Nivedita|Ivanov, Ivan|Pfent, Catherine M|Prudhomme, Kalan R|Bisson, William H|Dashwood, Roderick H|Talcott, Stephen T|Mertens-Talcott, Susanne U
PMID: 27028006
Journal: Mol Med Rep. 2017 Feb;15(2):867-872.
Title: Identification of key genes in colorectal cancer using random walk with restart.
Author: Cui, Xiaofeng|Shen, Kexin|Xie, Zhongshi|Liu, Tongjun|Zhang, Haishan
PMID: 28000901
Journal: J Nutr Biochem. 2017 May;43:11-17.
Title: A food-based approach that targets interleukin-6, a key regulator of chronic intestinal inflammation and colon carcinogenesis.
Author: Sido, Abigail|Radhakrishnan, Sridhar|Kim, Sung Woo|Eriksson, Elisabeth|Shen, Frank|Li, Qunhua|Bhat, Vadiraja|Reddivari, Lavanya|Vanamala, Jairam K P
PMID: 28193578
Journal: Cell Cycle. 2018 Nov 1.
Title: Up-regulation of microRNA-497 inhibits the proliferation, migration and invasion but increases the apoptosis of multiple myeloma cells through the MAPK/ERK signaling pathway by targeting Raf-1.
Author: Ye, Cheng-Yu|Zheng, Cui-Ping|Ying, Wei-Wei|Weng, Shan-Shan
PMID: 30382763